Aegis Capital

Yelp Inc (NYSE: YELP) is making changes to its business model but at the expense of near-term metrics, according to Aegis Capital.  The Analyst Aegis Capital Corp's Victor Anthony downgraded Yelp from Hold to Sell with a price target lowered from $45 to $34. The Thesis The bearish...

The U.S. Federal Trade Commission confirmed that it is investigating Facebook, Inc. (NASDAQ: FB) for potential misuse of customer data, and investors are understandably concerned about the potential for actions such as increased regulation and stiff penalties for the social media platform. The...

Facebook, Inc. (NASDAQ: FB)'s ongoing privacy saga has resulted in multiple high-profile companies suspending ties with the social media platform. Investors should expect the "storm to linger" in the near-term, but ultimately it "should pass," according to Aegis Capital....

Twitter Inc (NYSE: TWTR) reported a surprise earnings beat Thursday, catching some investors off guard. But at least one notable Wall Street wasn't surprised and was recommending investors buy the stock in 2017. The Analyst Aegis Capital's Victor Anthony. The Thesis The case for...

Heading into its Wednesday earnings report, Facebook Inc (NASDAQ: FB) is decidedly well liked. The firm’s 42 Buy ratings are tempered by just two Sells and one Hold, according to TipRanks, which records an average price target of $191.33 with a range of $98 to $235. Recent trends back the...

It is and always has been about technology. But contemporary disruptions in the innovative space, both inherent to sector players and imposed by outside economic forces, have bolstered some and crushed others. Victor Anthony, managing director of internet media at Aegis Capital, broke down the...

Aegis Capital's Victor Anthony was a guest on CNBC's "Squawk Box" segment on Thursday to offer his expert take on Facebook Inc (NASDAQ: FB), which celebrates its five-year anniversary as being a public company. First, Anthony discussed Facebook being slapped with a 110 million euro fine for...

Neurotrope Inc (NASDAQ: NTRP) is in the process of developing Bryostatin-1 “as a stimulator of PKCε, an early regulator of brain cell growth and repair. A Phase IIb trial has completed enrollment in Alzheimer’s disease, with data expected in late April 2017,” Aegis Capital...

HSN, Inc. (NASDAQ: HSNI) has delivered “slowing to negative growth” both at its HSN video commerce segment and at Cornerstone. While trends at the HSN segment may improve in the coming quarters, “we are less optimistic about the recovery path for Cornerstone,” Aegis Capital...

Shares of Celadon Group, Inc. (NYSE: CGI) plummeted Wednesday following a short-seller report published by Prescience Point Research Group. The pullback creates an opportunity since the concerns mentioned in the short report are not new and uses certain figures “in a distorted manner,”...